Then, inhibition of Vps34 kinase activity was shown to enhance PD-L1 expression in melanoma and colorectal cancers as well as PD-1 on CD45+ tumor-infiltrating cells (NK cells and both CD8+ and CD4+ T cells). The gene discussed is CD4; the disease is melanoma.